Global Interferon Alpha-2a Biosimilar Market Analysis 2015-2019 and Forecast 2020-2025

ReportPage
Report ID
82626
Published Date
02-Feb
No of Report Page
95
Report Category
Life Sciences
Editor's Rating
US $5,960.00
US $5,960.00
US $2,980.00

  • Report Details

    Snapshot
    Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
    The global Interferon Alp

    More...
  • Table Of Content

    Table of Content

    1 Industry Overview
    1.1 Interferon Alpha-2a Biosimilar Industry
    Figure Interferon Alpha-2a Biosimilar Industry Chain Structure
    1.1.1 Overview
    1.1.2 Development of Interferon Alpha-2a Biosimilar
    1.2 Market Segment
    1.2.1 Upstream
    Table Upstream Segment of Interferon Alpha-2a Biosimilar
    1.2.2 Downstream

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample